-
Subject Areas on Research
-
2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis.
-
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.
-
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.
-
2017 Version of LI-RADS for CT and MR Imaging: An Update.
-
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
-
3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial.
-
4D liver tumor localization using cone-beam projections and a biomechanical model.
-
5-Fluorouracil and high-dose calcium leucovorin for hepatocellular carcinoma: a phase II trial.
-
A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
-
A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients.
-
A Model for Adaptive Decision Making of "Ablate-and-Wait" Versus Transplantation in Patients With Hepatocellular Carcinoma.
-
A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function.
-
A Rapidly Enlarging Müllerian-Derived Hepatic Adenomyoma Clinically Mimicking Hepatic Adenoma in a Pregnant Woman.
-
A Simulation Paradigm for Evaluation of Subtle Liver Lesions at Pediatric CT: Performance and Confidence.
-
A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine.
-
A Technique for Generating Volumetric Cine-Magnetic Resonance Imaging.
-
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.
-
A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver.
-
A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: A diagnostic challenge and management dilemma.
-
A case-control method for assessing environmental risks from multiple industrial point sources.
-
A comparison of antiangiogenic therapies for the prevention of liver metastases.
-
A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function.
-
A dual-supervised deformation estimation model (DDEM) for constructing ultra-quality 4D-MRI based on a commercial low-quality 4D-MRI for liver cancer radiation therapy.
-
A farewell to Barcelona Clinic Liver Cancer (BCLC) classification for hepatocellular carcinoma.
-
A generic framework to simulate realistic lung, liver and renal pathologies in CT imaging.
-
A hyperspectral imaging system for in vivo optical diagnostics. Hyperspectral imaging basic principles, instrumental systems, and applications of biomedical interest.
-
A literature-based treatment algorithm for low-grade neuroendocrine liver metastases.
-
A long-term experience with expansion of Milan criteria for liver transplant recipients.
-
A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma.
-
A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA).
-
A niche role for cancer exosomes in metastasis.
-
A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.
-
A pathological fracture and a solitary mass in the right clavicle: an unusual first presentation of HCC and the role of immunohistochemistry.
-
A phase I-II trial of mitoxantrone by hepatic arterial infusion in patients with hepatocellular carcinoma or colorectal carcinoma metastatic to the liver.
-
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
-
A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer.
-
A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
-
A pressing situation.
-
A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.
-
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
-
A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases.
-
A role for hepatic metastasectomy in stage IV melanoma and breast cancer: reestablishing the surgical modality.
-
A segmental approach to computerized tomographic portography for hepatic resection.
-
A singular value decomposition linear programming (SVDLP) optimization technique for circular cone based robotic radiotherapy.
-
A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element.
-
ACE inhibitors: The secret to prevent cirrhosis complications and HCC in NAFLD?
-
ACR Appropriateness Criteria® Chronic Liver Disease.
-
ACR Appropriateness Criteria® Liver Lesion-Initial Characterization.
-
ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update.
-
AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma.
-
ALPPS Procedure for Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Revealing a Terra Incognita.
-
ASO Author Reflections: Implementation of a New Hepatic Artery Infusion Program for Colorectal Liver Metastases is Safe, Feasible, and Effective.
-
Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
-
Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
-
Accelerating volumetric cine MRI (VC-MRI) using undersampling for real-time 3D target localization/tracking in radiation therapy: a feasibility study.
-
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
-
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.
-
Acoustic radiation force elasticity imaging in diagnostic ultrasound.
-
Acoustic radiation force impulse imaging of the abdomen: demonstration of feasibility and utility.
-
Acoustic radiation force impulse imaging of thermally- and chemically-induced lesions in soft tissues: preliminary ex vivo results.
-
Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis.
-
Acting in the face of uncertainty.
-
Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
-
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.
-
Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?
-
Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
-
Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
-
Adenocarcinoma of the liver without a detectable primary.
-
Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases.
-
Adoption of Splenic Enhancement to Time and Trigger the Late Hepatic Arterial Phase During MDCT of the Liver: Proof of Concept and Clinical Feasibility.
-
Age differences in care practices and outcomes for hospitalized patients with cancer.
-
Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of Colon Cancer Liver Metastasis.
-
Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
-
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
-
Alpha-glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3-CD56+ NK cells in vitro.
-
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
-
An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
-
An international survey on liver metastases radiotherapy.
-
An update for LI-RADS: Version 2018. Why so soon after version 2017?
-
Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma.
-
Anatomic versus non-anatomic resection for hepatocellular carcinoma: A systematic review and meta-analysis.
-
Anesthetic management of a patient having a carcinoid syndrome.
-
Annual literature review for clinical transplants 2005.
-
Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells.
-
Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.
-
Antioxidants and prevention of gastrointestinal cancers.
-
Apoptosis and cytokines in non-alcoholic steatohepatitis.
-
Architectural pattern, tissue and cellular morphology in livers of fishes: relationship to experimentally-induced neoplastic responses.
-
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia.
-
Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).
-
Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
-
Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
-
Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers.
-
Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
-
Associating liver partition and portal vein ligation for staged hepatectomy in patients with primary liver malignancies: A systematic review of the literature.
-
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
-
Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States.
-
Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults.
-
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.
-
Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma.
-
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.
-
Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells.
-
BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis.
-
Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
-
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
-
Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
-
Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list.
-
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors.
-
Biochemical and histochemical properties of hepatic tumors of rainbow trout, Oncorhynchus mykiss.
-
Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol.
-
Breath-hold three-dimensional CT of the liver with multi-detector row helical CT.
-
Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
-
Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver.
-
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.
-
CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
-
CD24 as a Novel Predictive Biomarker in Patients with Hepatocellular Carcinoma: Friend or Foe?
-
CHML promotes liver cancer metastasis by facilitating Rab14 recycle.
-
CT arterial portography: causes of technical failure and variable liver enhancement.
-
CT during arterial portography: diagnostic pitfalls.
-
CT of fundoplication.
-
CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis.
-
CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear.
-
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
-
CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
-
CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine.
-
Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice.
-
Can MRI Features of Combined Hepatocellular Carcinoma-Intrahepatic Cholangiogarcinoma Help Predict Tumor Behavior Better than Histologic Findings?
-
Can Realistic Liver Tissue Surrogates Accurately Quantify the Impact of Reduced-kV Imaging on Attenuation and Contrast of Parenchyma and Lesions?
-
Carcinoid metastases to the liver: role of triple-phase helical CT.
-
Carcinoid tumors of the gastrointestinal tract. A review and the Duke University institutional overview.
-
Case 23-2005: a man with a mass in the liver.
-
Case report. Intrabiliary colonic metastasis mimicking primary biliary neoplasia.
-
Cases from the Osler Medical Service at Johns Hopkins University.
-
Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology.
-
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity.
-
Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison.
-
Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.
-
Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.
-
Challenges in screening for hepatocellular carcinoma in the glycogen storage disease type 1a population.
-
Challenging choices: liver transplantation for hepatocellular carcinoma.
-
Changes in the management of benign liver tumours: an analysis of 285 patients.
-
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.
-
Characterization and pathogenesis of anemia in glycogen storage disease type Ia and Ib.
-
Characterization of Small Incidental Indeterminate Hypoattenuating Hepatic Lesions: Added Value of Single-Phase Contrast-Enhanced Dual-Energy CT Material Attenuation Analysis.
-
Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
-
Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.
-
Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer.
-
Childhood hepatic mesenchymoma: successful treatment with surgery and multiple-agent chemotherapy.
-
Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF-PU.1-DPP4 Axis.
-
Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.
-
Cirrhosis of the liver in long-term marrow transplant survivors.
-
Cisplatin and 5-fluorouracil infusion for metastatic colorectal carcinoma. Differences in survival in two patient groups with similar response rates.
-
Clear cell sarcoma of the gastrointestinal tract after very low-dose therapeutic radiation therapy: a case report.
-
Cleavable Multifunctional Targeting Mixed Micelles with Sequential pH-Triggered TAT Peptide Activation for Improved Antihepatocellular Carcinoma Efficacy.
-
Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.
-
Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.
-
Clinical impact of an adaptive statistical iterative reconstruction algorithm for detection of hypervascular liver tumours using a low tube voltage, high tube current MDCT technique.
-
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis.
-
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
-
Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein.
-
Clinico-pathologic conference: 12-year-old girl with fatigue, anemia, weight loss, abdominal distention, and occasional nausea and vomiting.
-
Clostridium septicum abscess in hepatic metastases: successful medical management.
-
Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy.
-
Code Abdomen: An Assessment Coding Scheme for Abdominal Imaging Findings Possibly Representing Cancer.
-
Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.
-
Colon cancer, version 3.2014.
-
Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation.
-
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
-
Colorectal Cancer Liver Metastases: Multimodal Therapy.
-
Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.
-
Combination gene therapy for liver metastasis of colon carcinoma in vivo.
-
Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Work in progress.
-
Combined Primary Resection with Hepatic Artery Infusion Pump Implantation Is Safe for Unresectable Colorectal Liver Metastases.
-
Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.
-
Combined hepatocellular and cystadenocarcinoma presenting as a giant cyst of the liver--a case report.
-
Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
-
Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas.
-
Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer.
-
Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
-
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
-
Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene.
-
Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging.
-
Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma.
-
Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
-
Computed tomography in the detection of abdominal metastases from malignant melanoma.
-
Computed tomography of primary liver tumors in children.
-
Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma.
-
Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
-
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.
-
Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.
-
Contemporary surgical options for metastatic colorectal cancer.
-
Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.
-
Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
-
Cryosurgery after chemoembolization for hepatocellular carcinoma in patients with cirrhosis.
-
Cryosurgical debulking of unresectable liver metastases for palliation of carcinoid syndrome.
-
Current Approaches in the Management of Hepatic Adenomas.
-
Current status of hepatic resection.
-
Cytoablative therapy with combined resection and cryosurgery for limited bilobar hepatic colorectal metastases.
-
Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
-
Cytotoxicity phase of diethylnitrosamine-induced hepatic neoplasia in medaka.
-
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
-
Data-Driven Modification of the LI-RADS Major Feature System on Gadoxetate Disodium-Enhanced MRI: Toward Better Sensitivity and Simplicity.
-
Decreased detection of hypovascular liver tumors with MDCT in obese patients: a phantom study.
-
Deep Learning-Based Assessment of Functional Liver Capacity Using Gadoxetic Acid-Enhanced Hepatobiliary Phase MRI.
-
Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
-
Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.
-
Desmoplastic small round cell tumor: using FISH as an ancillary technique to support cytologic diagnosis in an unusual case.
-
Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases.
-
Detection of Colorectal Hepatic Metastases Is Superior at Standard Radiation Dose CT versus Reduced Dose CT.
-
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy.
-
Detection of focal hepatic masses: STIR MR vs. CT during arterial portography.
-
Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
-
Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.
-
Detection of liver masses with spiral computed tomography.
-
Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy.
-
Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map.
-
Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
-
Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.
-
Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
-
Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy: a clinical and pathologic correlation of 298 cases.
-
Diagnostic approach to hepatic hemangiomas.
-
Diagnostic criteria for degenerative, inflammatory, proliferative nonneoplastic and neoplastic liver lesions in medaka (Oryzias latipes): consensus of a National Toxicology Program Pathology Working Group.
-
Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.
-
Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT.
-
Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality.
-
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
-
Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta.
-
Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.
-
Diffuse neonatal hemangiomatosis: imaging findings in two patients.
-
Digital tomosynthesis for respiratory gated liver treatment: clinical feasibility for daily image guidance.
-
Digital tomosynthesis with an on-board kilovoltage imaging device.
-
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
-
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
-
Disappearing liver metastases: A systematic review of the current evidence.
-
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.
-
Discussion.
-
Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.
-
Does the presence of coronary artery disease impact perioperative outcomes following partial hepatectomy?
-
Donor-Derived Neuroendocrine Carcinoma Transmission to Two Kidney Transplant Recipients Demonstrated by Short Tandem Repeat Analysis: A Case Report.
-
Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.
-
Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
-
Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy.
-
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.
-
Dual-Energy Multidetector Computed Tomography With Iodine Quantification in the Evaluation of Portal Vein Thrombosis: Is It Possible to Discard the Unenhanced Phase?
-
Dual-Enzyme-Loaded Multifunctional Hybrid Nanogel System for Pathological Responsive Ultrasound Imaging and T2-Weighted Magnetic Resonance Imaging.
-
Dual-Source Single-Energy Multidetector CT Used to Obtain Multiple Radiation Exposure Levels within the Same Patient: Phantom Development and Clinical Validation.
-
Dual-energy MDCT in hypervascular liver tumors: effect of body size on selection of the optimal monochromatic energy level.
-
Dual-phase 3D MDCT angiography for evaluation of the liver before hepatic resection.
-
Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
-
Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer.
-
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis.
-
E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma.
-
EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
-
EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases.
-
Early trends in serum phosphate and creatinine levels are associated with mortality following major hepatectomy.
-
Editorial: frequency of surveillance and survival in hepatocellular carcinoma-authors' reply.
-
Effect of Radiation Dose Reduction and Reconstruction Algorithm on Image Noise, Contrast, Resolution, and Detectability of Subtle Hypoattenuating Liver Lesions at Multidetector CT: Filtered Back Projection versus a Commercial Model-based Iterative Reconstruction Algorithm.
-
Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.
-
Effect of a Noise-Optimized Second-Generation Monoenergetic Algorithm on Image Noise and Conspicuity of Hypervascular Liver Tumors: An In Vitro and In Vivo Study.
-
Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study.
-
Effect of epidural compared to patient-controlled intravenous analgesia on outcomes for patients undergoing liver resection for neoplastic disease.
-
Effect of exposure to light-at-night on life span and spontaneous carcinogenesis in female CBA mice.
-
Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. I. Effect of amino acid supply.
-
Effect of growth conditions on the activity of ornithine decarboxylase in cultured hepatoma cells. II. Effect of serum and insulin.
-
Effect of growth conditions on the ornithine decarboxylase activity of rat hepatoma cells.
-
Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.
-
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.
-
Effect of radiologists' experience with an adaptive statistical iterative reconstruction algorithm on detection of hypervascular liver lesions and perception of image quality.
-
Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer.
-
Effect of tumor size and tumor-to-liver contrast of hypovascular liver tumors on the diagnostic performance of hepatic CT imaging.
-
Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
-
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer.
-
Effectiveness of Transarterial Embolization of Hepatocellular Carcinoma as a Bridge to Transplantation.
-
Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation.
-
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.
-
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
-
Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial.
-
Electrophoretic analysis of four high molecular weight sialoglycoproteins produced by metastatic human colon carcinoma cells.
-
Endometriosis of the liver containing mullerian adenosarcoma: case report.
-
Endoscopic palliation of a biliocutaneous fistula with expandable metal stents.
-
Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.
-
Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma.
-
Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
-
Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis.
-
Epithelial-mesenchymal transitions and hepatocarcinogenesis.
-
Estimating Tumor Growth Rates In Vivo.
-
Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression.
-
Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells.
-
Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.
-
Evaluation of a simpler technique for in-vivo labelling of red blood cells with 99mTc.
-
Evaluation of dosimetric uncertainty caused by MR geometric distortion in MRI-based liver SBRT treatment planning.
-
Evaluation of the liver for metastatic disease.
-
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
-
Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases.
-
Examining reoperation and readmission after hepatic surgery.
-
Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
-
Experience with more than 500 minimally invasive hepatic procedures.
-
Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study.
-
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline.
-
FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
-
Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?
-
Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
-
Fine needle aspiration biopsy of the liver.
-
Fine-needle aspiration of choroidal melanoma metastatic to the liver.
-
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.
-
Focal fatty infiltration: a cause of nontumorous defects in the left hepatic lobe during CT arterial portography.
-
Focal hepatic lesions: detection by dynamic and delayed computed tomography versus short TE/TR spin echo and fast field echo magnetic resonance imaging.
-
Focal intrahepatic extramedullary hematopoiesis mimicking neoplasm.
-
Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma?
-
Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history.
-
Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
-
Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance.
-
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.
-
Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion.
-
Four-dimensional magnetic resonance imaging using axial body area as respiratory surrogate: initial patient results.
-
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
-
Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era.
-
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
-
Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
-
Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver.
-
Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
-
Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.
-
Gastric adenocarcinoma: CT versus surgical staging.
-
Gastroduodenal ulcerations in patients receiving selective hepatic artery infusion chemotherapy.
-
Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
-
Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer.
-
Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
-
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction.
-
Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.
-
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors.
-
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes.
-
Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.
-
Glutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinoma.
-
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
-
Glycogen storage disease types I and II: treatment updates.
-
Gray scale ultrasound and isotope scanning: complementary techniques for imaging the liver.
-
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
-
HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer.
-
Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.
-
Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.
-
Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase.
-
Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma.
-
Hepatic Arterial Infusion Pumps: What the Radiologist Needs to Know.
-
Hepatic Artery Infusion Pumps: A Surgical Toolkit for Intraoperative Decision-Making and Management of Hepatic Artery Infusion-Specific Complications.
-
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients.
-
Hepatic adenoma and focal nodular hyperplasia.
-
Hepatic adenoma: MR appearance mimicking focal nodular hyperplasia.
-
Hepatic adenoma: MR characteristics and correlation with pathologic findings.
-
Hepatic angiomyolipoma and hepatic stellate cells share a similar gene expression profile.
-
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.
-
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
-
Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease.
-
Hepatic complications of obesity.
-
Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents.
-
Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids.
-
Hepatic hemangiomas vs metastases: MR differentiation at 1.5 T.
-
Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
-
Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma.
-
Hepatic metastasis from neuroblastoma.
-
Hepatic metastasis of a carotid body paraganglioma 5 years after resection of the primary tumor.
-
Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.
-
Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?
-
Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy.
-
Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.
-
Hepatic resection for hepatocellular carcinoma: do contemporary morbidity and mortality rates demand a transition to ablation as first-line treatment?
-
Hepatic resection for metastatic cancer.
-
Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.
-
Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.
-
Hepatic vascular malignancies in children are associated with increased rates of surgical resection and improved overall survival compared with adults.
-
Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
-
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
-
Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
-
Hepatitis C.
-
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
-
Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.
-
Hepatobiliary cystadenoma with mesenchymal stroma.
-
Hepatobiliary phase MRI: impact on planning image-guided liver tumor ablations.
-
Hepatobiliary phase hypointensity predicts progression to hepatocellular carcinoma for intermediate-high risk observations, but not time to progression.
-
Hepatoblastoma diagnosed in infancy occurring in single-ventricle patients: a case series.
-
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.
-
Hepatocellular Carcinoma-The Influence of Immunoanatomy and the Role of Immunotherapy.
-
Hepatocellular adenoma among adult survivors of childhood and young adult cancer.
-
Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach.
-
Hepatocellular carcinoma and model for end-stage liver disease exceptions: the more we understand, the more challenging the allocation gets.
-
Hepatocellular carcinoma arising from ectopic liver tissue in the pancreas.
-
Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.
-
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.
-
Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout.
-
Hepatocellular carcinoma in glycogen storage disease type Ia: a case series.
-
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
-
Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
-
Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
-
Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (≤2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up.
-
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
-
Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
-
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature.
-
Hepatocellular carcinoma.
-
Hepatocellular carcinoma: clinical and angiographic findings and predictability for surgical resection.
-
Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms.
-
Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review.
-
Hepatosplenic T-cell lymphoma with blastoid morphology in a patient with Crohn disease.
-
Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation.
-
Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.
-
High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liver-limited metastatic colorectal cancer.
-
Histone deacetylase inhibitors in hepatocellular carcinoma: A therapeutic perspective.
-
Histopathological growth patterns and positive margins after resection of colorectal liver metastases.
-
Histopathological prognostic factors influencing long-term prognosis after surgical resection for hepatic metastases from colorectal cancer.
-
Hospital readmissions after liver surgery for metastatic colorectal cancer.
-
How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
-
How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma.
-
Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers.
-
Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.
-
Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.
-
Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
-
Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection--phantom study.
-
Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience.
-
I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.
-
Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers.
-
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
-
Identification of liver cancer-specific aptamers using whole live cells.
-
Ignore reality but not the consequences of its ignorance: Broaden guidelines in surgery of hepatocellular carcinoma.
-
Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device--initial observations.
-
Imaging in Patients with Cirrhosis: Current Evidence.
-
Imaging in the preoperative evaluation of adult liver-transplant candidates: goals, merits of various procedures, and recommendations.
-
Imaging of patients with potentially resectable hepatic neoplasms.
-
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA.
-
Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
-
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
-
Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor.
-
Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
-
Impact of Reference Standard on CT, MRI, and Contrast-enhanced US LI-RADS Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
-
Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis.
-
Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions.
-
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
-
Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer.
-
Impact of steatosis on perioperative outcome following hepatic resection.
-
Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma.
-
Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein.
-
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases.
-
Implementation of an Automated Radiology Recommendation-Tracking Engine for Abdominal Imaging Findings of Possible Cancer.
-
Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.
-
Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma.
-
Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging.
-
Improved survival and higher rates of surgical resection associated with hepatocellular carcinoma in children as compared to young adults.
-
Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.
-
Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
-
In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous.
-
In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.
-
In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography.
-
In vivo selection of tumor-targeting RNA motifs.
-
In vivo visualization of abdominal malignancies with acoustic radiation force elastography.
-
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors.
-
Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma.
-
Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
-
Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.
-
Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes.
-
Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients.
-
Inhibition of the growth of human melanoma metastases in nude mice by melanoma-specific murine monoclonal antibody.
-
Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
-
Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction.
-
Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.
-
Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
-
Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.
-
Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC.
-
Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma.
-
Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation.
-
Intrahepatic, extramedullary hematopoiesis mimicking hemangioma on technetium-99m red blood cell SPECT examination.
-
Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
-
Intrathoracic metastasis from an extrathoracic malignancy: a radiographic approach to patient evaluation.
-
Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma.
-
Investigation of sagittal image acquisition for 4D-MRI with body area as respiratory surrogate.
-
Invited Commentary: Key Role of Imaging in Management and Prognosis of Hepatocellular Carcinoma.
-
Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.
-
Iron negative foci and nodules in safrole-exposed mouse liver made siderotic by iron-dextran injection.
-
Irreversible electroporation (Nanoknife® treatment) in the field of hepatobiliary surgery: Current status and future perspectives.
-
Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
-
Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
-
Is diaphragm motion a good surrogate for liver tumor motion?
-
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
-
Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis?
-
Is there a role for simultaneous hepatic and colorectal resections? A contemporary view from NSQIP.
-
Isolated liver metastasis from a malignant phyllodes presenting with hemoperitoneum.
-
Isolation of a transplantable cell line induced by the MC29 avian leukosis virus.
-
Iterative reconstruction algorithm for abdominal multidetector CT at different tube voltages: assessment of diagnostic accuracy, image quality, and radiation dose in a phantom study.
-
KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.
-
Kinetics of liver volume changes in the first year after portal vein embolization.
-
LI-RADS 2017: An update.
-
LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy.
-
LI-RADS ancillary feature prediction of longitudinal category changes in LR-3 observations: an exploratory study.
-
LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
-
LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data.
-
LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.
-
LI-RADS: a glimpse into the future.
-
LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.
-
Laparoscopic Hepatectomy for Hepatocellular Carcinoma: The Opportunities, the Challenges, and the Limitations.
-
Laparoscopic liver surgery: a synopsis.
-
Laparoscopic major hepatectomy: an evolution in standard of care.
-
Laparoscopic staging for hepatobiliary carcinoma.
-
Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.
-
Laparoscopic versus open liver resection: a matched-pair case control study.
-
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role.
-
Less is more: salvageability as the new creed in surgery of colorectal liver metastatic disease.
-
Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3.
-
Leveraging Artificial Intelligence to Enhance Peer Review: Missed Liver Lesions on Computed Tomographic Pulmonary Angiography.
-
Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor.
-
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
-
Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma.
-
Liver MR imaging: comparison of respiratory triggered fast spin echo with T2-weighted spin-echo and inversion recovery.
-
Liver Mass: Thinking Out of the Box.
-
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
-
Liver Tumor Microenvironment.
-
Liver and abdominal screening in patients with cancer: CT versus MR imaging.
-
Liver and intestine transplantation in the United States 1998-2007.
-
Liver and intestine transplantation in the United States, 1997-2006.
-
Liver and prostate adenocarcinoma: an "estrogen-free" environment?
-
Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center.
-
Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Akt/NF-kappaB signaling pathway.
-
Liver function tests: inadequate screening modality for detection of liver metastasis in head and neck carcinoma.
-
Liver imaging with multidetector helical computed tomography.
-
Liver imaging: it is time to adopt standardized terminology.
-
Liver metastases from breast cancer: long-term survival after curative resection.
-
Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases.
-
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
-
Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?
-
Liver renewal: detecting misrepair and optimizing regeneration.
-
Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.
-
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.
-
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
-
Liver transplantation for glycogen storage disease type Ia.
-
Liver transplantation for hepatocellular carcinoma: Management after the transplant.
-
Liver transplantation for liver malignancies in Wilson's disease: two novel cases.
-
Liver transplantation for the treatment of hepatocellular carcinoma.
-
Liver transplantation for unresectable colorectal liver metastases.
-
Liver transplantation for unresectable colorectal liver metastases: A systematic review.
-
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
-
Liver transplantation.
-
Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.
-
Liver: single breath-hold dynamic subtraction CT with multi-detector row helical technology feasibility study.
-
Living and deceased donor liver transplantation for unresectable hepatoblastoma at a single center.
-
Living donor liver transplantation.
-
Local Tumor Control and Patient Outcome Using Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: iRECIST as a Potential Substitute for Traditional Criteria.
-
Local control and results of Leksell Gamma Knife therapy for the treatment of uveal melanoma.
-
Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
-
Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
-
Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
-
Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.
-
Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer.
-
Long-term outcomes following microwave ablation for liver malignancies.
-
Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases.
-
Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
-
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
-
Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver.
-
Long-term trends in liver neoplasms in brown bullhead in the Buffalo River, New York, USA.
-
Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression.
-
Loss of KAI1 expression in the progression of colorectal cancer.
-
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.
-
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
-
Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
-
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.
-
Low-tube-voltage, high-tube-current multidetector abdominal CT: improved image quality and decreased radiation dose with adaptive statistical iterative reconstruction algorithm--initial clinical experience.
-
Luftsichel sign upperlobe collapse.
-
Lysyl oxidase is essential for hypoxia-induced metastasis.
-
MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases.
-
MELD-Na Accurately Predicts 6-Month Mortality in Patients With Decompensated Cirrhosis: Potential Trigger for Hospice Referral.
-
MR Imaging of Diffuse Liver Disease.
-
MR of focal liver lesions: comparison of breath-hold and non-breath-hold hybrid RARE and conventional spin-echo T2-weighted pulse sequences.
-
MR-PET co-registration in upper abdominal imaging: quantitative comparison of two different T1-weighted gradient echo sequences: initial observations.
-
MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.
-
MRI-based treatment planning for liver stereotactic body radiotherapy: validation of a deep learning-based synthetic CT generation method.
-
MRI-based treatment planning for proton radiotherapy: dosimetric validation of a deep learning-based liver synthetic CT generation method.
-
Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance.
-
Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.
-
Major liver resection in elderly patients: a multi-institutional analysis.
-
Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability.
-
Management implications and outcomes of LI-RADS-2, -3, -4, and -M category observations.
-
Management of advanced neuroendocrine tumors with hepatic metastasis.
-
Management of hepatocellular adenoma: comparison of resection, embolization and observation.
-
Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx Collaborative.
-
Management, outcomes, and prognostic factors of ruptured hepatocellular carcinoma: A systematic review.
-
Mechanisms of disease progression in nonalcoholic fatty liver disease.
-
Mechanistic insights of rapid liver regeneration after associating liver partition and portal vein ligation for stage hepatectomy.
-
Menorrhagia in patients with type I glycogen storage disease.
-
Mesenchymal stem cells support growth and organization of host-liver colorectal-tumor organoids and possibly resistance to chemotherapy.
-
Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
-
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.
-
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
-
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody.
-
Metastatic lesions arising in a Riedel's lobe. Findings from a sulfur colloid liver-spleen scan.
-
Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens.
-
Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
-
MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma.
-
Minimal Risk of Biliary Tract Complications, Including Hepatic Abscess, After Transarterial Embolization for Hepatocellular Carcinoma Using Concentrated Antibiotics Mixed with Particles.
-
Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.
-
Minimally invasive liver resection for metastatic colorectal cancer: a multi-institutional, international report of safety, feasibility, and early outcomes.
-
Mitochondrial transcription factor A induction by redox activation of nuclear respiratory factor 1.
-
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.
-
Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: A Secondary Analysis of a Prospective Observational Study.
-
Molecularly targeted therapies for hepatocellular carcinoma: sorafenib as a stepping stone.
-
Multi-contrast four-dimensional magnetic resonance imaging (MC-4D-MRI): Development and initial evaluation in liver tumor patients.
-
Multi-institutional analysis of recurrence and survival after hepatectomy for fibrolamellar carcinoma.
-
Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.
-
Multiphase multi-detector row computed tomography in the setting of chronic liver disease and orthotopic liver transplantation: can a series be eliminated in order to reduce radiation dose?
-
Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea.
-
Murine bone marrow stromal cells pulsed with homologous tumor-derived exosomes inhibit proliferation of liver cancer cells.
-
Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.
-
Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.
-
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
-
NAFLD and extrahepatic cancers: have a look at the colon.
-
NAFLD, NASH and liver cancer.
-
NASH in HIV.
-
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
-
NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.
-
NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases.
-
Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer.
-
Negative biopsies, deadly disease: metastatic angiosarcoma.
-
Neuroendocrine carcinomas of the gallbladder: Lessons learnt from cases at opposite ends of the spectrum.
-
New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma.
-
New observation of sialuria prompts detection of liver tumor in previously reported patient.
-
Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells.
-
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
-
Nodular regenerative hyperplasia in partial hepatectomy specimens.
-
Non-Hodgkin lymphoma presenting with obstructive jaundice.
-
Non-genetic risk factors and predicting efficacy for docetaxel--drug-induced liver injury among metastatic breast cancer patients.
-
Non-hepatocellular carcinoma spinal metastases.
-
Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes.
-
Nonalcoholic Fatty Liver Disease Among Individuals with HIV Mono-infection: A Growing Concern?
-
Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
-
Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
-
Nonparametric estimation and inference for polytomous discrimination index.
-
Not by blood alone: diagnosis of hemangiomas by fine-needle aspiration.
-
Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.
-
Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study.
-
Novikoff hepatoma deoxyribonucleic acid polymerase. Sensitivity of the beta-polymerase to sulfhydryl blocking agents.
-
Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.
-
On confirmation bias in imaging research.
-
Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.
-
Oncologic outcomes after laparoscopic versus open resection for colorectal liver metastases.
-
Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis.
-
Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
-
Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series.
-
Opportunities for targeted therapies in hepatocellular carcinoma.
-
Opposite effects of lead on chemical carcinogenesis in kidney and liver of rats.
-
Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation.
-
Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis.
-
Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.
-
Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.
-
Oral administration of an Enoki mushroom protein FVE activates innate and adaptive immunity and induces anti-tumor activity against murine hepatocellular carcinoma.
-
Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model.
-
Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
-
Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium.
-
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
-
Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma.
-
Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
-
Overall survival or other clinical benefits from adjuvant selective intraarterial chemotherapy in patients undergoing curative liver resection for metastatic colorectal tumor.
-
Overcoming Treatment Disparities for Early-Stage Hepatocellular Carcinoma in the Veteran Population: Is the MISSION Act the Solution?
-
Overexpression of caspase-3 in hepatocellular carcinomas.
-
Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses.
-
Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma.
-
Overview of stereotactic body radiotherapy and the nursing role.
-
Oxygen flux analysis to understand the biological function of sirtuins.
-
PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors.
-
PGC-1beta in the regulation of hepatic glucose and energy metabolism.
-
Pancreas and liver resection in Jehovah's Witness patients: feasible and safe.
-
Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
-
Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma.
-
Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
-
Parenchymal-sparing Hepatectomy as the New Doctrine in the Treatment of Liver-metastatic Colorectal Disease: Beyond Oncological Outcomes.
-
Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium.
-
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome.
-
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
-
Pathology and imaging of hepatocellular neoplasms: are findings from Asian populations applicable to non-Asian groups?
-
Patient Triage for Resection of Metastatic Colorectal Cancer to the Liver: Can We Do Better Using MRI?
-
Patient and tumor characteristics predictive of an elevated hepatopulmonary shunt fraction before radioembolization of hepatic tumors.
-
Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception.
-
Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma.
-
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer.
-
Patterns of recurrence after ablation of colorectal cancer liver metastases.
-
Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee.
-
Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
-
Percutaneous transhepatic choledochocholedochostomy in the management of the postoperative patient.
-
Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.
-
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases.
-
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.
-
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
-
Personalized treatment in patients with colorectal liver metastases.
-
Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.
-
Pharmacokinetics of combined gene therapy expressing constitutive human GM-CSF and hyperthermia-regulated human IL-12.
-
Phase 1 study of N(1),N(11)‑diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
-
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma.
-
Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98).
-
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
-
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM).
-
Phase II study of stereotactic radiosurgery for the treatment of patients with oligoprogression on erlotinib.
-
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
-
Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.
-
Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.
-
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
-
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.
-
Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers.
-
Physician-assisted suicide and advance directives concerning life support.
-
Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
-
Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
-
Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.
-
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
-
Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome.
-
Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors.
-
Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
-
Predicting real-time 3D deformation field maps (DFM) based on volumetric cine MRI (VC-MRI) and artificial neural networks for on-board 4D target tracking: a feasibility study.
-
Predicting recurrence patterns after resection of hepatocellular cancer.
-
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.
-
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.
-
Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
-
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.
-
Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study.
-
Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma.
-
Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.
-
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis.
-
Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation.
-
Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.
-
Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
-
Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography.
-
Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.
-
Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis.
-
Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.
-
Primary Hepatic Lymphoma Complicated by a Hepatic Inflammatory Pseudotumor and Tumor-Forming Pancreatitis.
-
Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival.
-
Primary hepatic neoplasms arising in cirrhotic livers can have a variable spectrum of neuroendocrine differentiation.
-
Primary high-grade neuroendocrine carcinoma emerging from an adenomatous polyp in the setting of familial adenomatous polyposis.
-
Primary leiomyoma of the liver.
-
Primary malignant fibrous histiocytoma of the liver MRI findings.
-
Problems for risk assessment of endocrine-active estrogenic compounds.
-
Proceed with caution: liver transplantation for metastatic neuroendocrine tumors.
-
Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System.
-
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
-
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
-
Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.
-
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
-
Prognostic factors in the initial response to therapy by patients with advanced breast cancer.
-
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma.
-
Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
-
Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis.
-
Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma.
-
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
-
Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer.
-
Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement.
-
Program death-1 immune checkpoint and tumor microenvironment in malignant liver tumors.
-
Progression of Treated versus Untreated Liver Imaging Reporting and Data System Category 4 Masses after Transcatheter Arterial Embolization Therapy.
-
Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma.
-
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
-
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
-
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
-
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
-
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.
-
Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
-
Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions.
-
Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded Cohort.
-
Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.
-
Quantitative perfusion imaging of neoplastic liver lesions: A multi-institution study.
-
RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
-
Radiation-associated liver injury.
-
Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description.
-
Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
-
Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.
-
Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers.
-
Radiofrequency ablation of liver tumors: influence of technique and tumor size.
-
Radiologic-pathologic analysis of increased ethanol localization and ablative extent achieved by ethyl cellulose.
-
Radiologic-pathologic correlation of uncommon mesenchymal liver tumors.
-
Radiological evaluation of metastases to the liver: The Emory experience.
-
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
-
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
-
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
-
Rapid degradation of puromycyl peptides in hepatoma cells and reticulocytes.
-
Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center.
-
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases.
-
Reassessing hepatocellular carcinoma staging in a changing patient population.
-
Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii.
-
Rectal cancer: presentation with metastatic and locally advanced disease. American College of Radiology. ACR Appropriateness Criteria.
-
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection.
-
Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
-
Recurrence patterns following irreversible electroporation for hepatic malignancies.
-
Recurrent Burkitt's lymphoma mimicking toxic veno-occlusive disease of the liver.
-
Recurrent tumor after resection of hepatic metastases from colorectal carcinoma: location and time of discovery as determined by CT.
-
Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases.
-
Referring Provider Perceptions of Standardized Reporting for Possible Abdominal Cancer.
-
Refractory myasthenia gravis exacerbation triggered By pembrolizumab.
-
Regression of metastatic breast cancer in a patient treated with the anti-angiogenic drug TNP-470.
-
Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.
-
Reply to A. Braillon, M. Boulin et al, and J.-H. Zhong et al.
-
Reproducibility of CT Radiomic Features within the Same Patient: Influence of Radiation Dose and CT Reconstruction Settings.
-
Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?
-
Resection of adrenocortical carcinoma liver metastasis: is it justified?
-
Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia.
-
Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.
-
Residual motion mitigation in scanned carbon ion beam therapy of liver tumors using enlarged pencil beam overlap.
-
Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver.
-
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
-
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
-
Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.
-
Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
-
Ring finger protein 121 is a potent regulator of adeno-associated viral genome transcription.
-
Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
-
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
-
Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis.
-
Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis.
-
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.
-
Robotic Liver Resection: A Case-Matched Comparison.
-
Role of computed tomography in screening for hepatocellular carcinoma in patients with cirrhosis.
-
Role of exosomes in treatment of hepatocellular carcinoma.
-
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
-
Safety and oncologic outcomes of robotic liver resections: A systematic review.
-
Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey.
-
Scintigraphy, ultrasound and CT scanning of the liver.
-
Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria.
-
Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma.
-
Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma.
-
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
-
Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement.
-
Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.
-
Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure.
-
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis.
-
Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar Carcinoma.
-
Single-incision laparoscopic liver resection.
-
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
-
Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center.
-
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model.
-
Sorafenib use for recurrent hepatocellular cancer after resection or transplantation: Observations from a US regional analysis of the GIDEON registry.
-
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial.
-
Sorting multiple classes in multi-dimensional ROC analysis: parametric and nonparametric approaches.
-
Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis.
-
Spindle-cell lesions of the liver: diagnosis by fine-needle aspiration biopsy.
-
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
-
State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.
-
Stemming the tide of hepatitis B virus related hepatocellular carcinoma?
-
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
-
Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report.
-
Structural characterization of the 5' regions of the human phenylalanine hydroxylase gene.
-
Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib.
-
Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging.
-
Successful treatment of immune thrombocytopenic purpura with anti-D antibody following a cadaveric liver transplant for hepatoblastoma.
-
Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
-
Surgery or ablative radiotherapy for breast cancer oligometastases.
-
Surgical Management of Colorectal Cancer Liver Metastases.
-
Surgical clearance for the patient with chronic liver disease.
-
Surgical options for advanced/metastatic gastrointestinal stromal tumors.
-
Surgical resection for benign and malignant liver disease.
-
Surgical resection for small hepatocellular carcinoma.
-
Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
-
Surveillance for hepatocellular carcinoma.
-
Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.
-
Sustained expression of human factor VIII in mice using a parvovirus-based vector.
-
Synchronous Hemihepatectomy With Pancreatectomy Through Application of Associated Liver Partition and Portal Vein Ligation for a Metastatic Gastrinoma.
-
Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management?
-
Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
-
Synchronous resection of esophageal cancer and other organ malignancies: A systematic review.
-
Synchronous resection of primary and liver metastases for neuroendocrine tumors.
-
Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers.
-
T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI.
-
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.
-
Targeting Histone Deacetylase 6 Reprograms Interleukin-17-Producing Helper T Cell Pathogenicity and Facilitates Immunotherapies for Hepatocellular Carcinoma.
-
Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
-
Targeting Tumor-Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies.
-
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.
-
Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies.
-
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases.
-
Technical modifications and outcomes after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for primary liver malignancies: A systematic review.
-
Technique for MR imaging of the liver.
-
Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis.
-
Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial.
-
The ALPPS procedure as a novel "liver-first" approach in treating liver metastases of colon cancer: the first experience in Greek Cypriot area.
-
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases.
-
The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
-
The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis.
-
The Genetic Basis of Hepatosplenic T-cell Lymphoma.
-
The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial.
-
The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
-
The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma.
-
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
-
The Prognosis of Hepatocellular Carcinoma Treated with Sorafenib in Combination with TACE.
-
The Role of Angiogenesis in Hepatocellular Carcinoma.
-
The Role of Surgery for Pancreatic Neuroendocrine Tumors.
-
The Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis.
-
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer.
-
The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer.
-
The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.
-
The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma.
-
The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies.
-
The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.
-
The diagnostic accuracy/efficacy of MRI in differentiating hepatic hemangiomas from metastatic colorectal/breast carcinoma: a multiple reader ROC analysis using a jackknife technique.
-
The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma.
-
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
-
The effect of protein nutrition on host and tumor metabolism.
-
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
-
The effects of hepatic cryosurgery on tumor growth in the liver.
-
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
-
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens.
-
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
-
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.
-
The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT.
-
The hedgehog pathway in nonalcoholic fatty liver disease.
-
The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer.
-
The induction of ornithine decarboxylase in cultured hepatoma cells.
-
The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation.
-
The management of variant arterial anatomy during hepatic arterial infusion pump placement.
-
The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.
-
The natural history of hepatitis C viral infection.
-
The potential role of preoperative portal vein embolization for the prevention of small-for-size syndrome.
-
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
-
The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer.
-
The role of Hedgehog signaling in fibrogenic liver repair.
-
The role of external beam radiotherapy in the treatment of hepatocellular cancer.
-
The struggle for intensive care coverage of patients with hepatobiliary malignancies in Greece: Patients are not numbers.
-
The subcellular localization of syntaxin 17 varies among different cell types and is altered in some malignant cells.
-
The unique identity of rat hepatoma phenylalanine hydroxylase.
-
The use of ultrasound to enhance the diagnostic utility of the equivocal liver scintigraph.
-
The utility of micro-CT and MRI in the assessment of longitudinal growth of liver metastases in a preclinical model of colon carcinoma.
-
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention.
-
Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention.
-
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.
-
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation.
-
Timing Is Everything.
-
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
-
Tissue- and development-specific expression of the human phenylalanine hydroxylase/chloramphenicol acetyltransferase fusion gene in transgenic mice.
-
To ablate or not to ablate?: that is the question.
-
Towards a definite mouse model of NAFLD.
-
Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.
-
Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism.
-
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
-
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.
-
Transplanted carcinoma in an immunosuppressed patient.
-
Travel distance and overall survival in hepatocellular cancer care.
-
Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?
-
Treatment of advanced colorectal cancer.
-
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease.
-
Treatment of giant hemangiomas of the liver by enucleation.
-
Treatment of human melanoma hepatic metastases in nude mice with human cytotoxic T lymphocytes.
-
Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities.
-
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.
-
Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases.
-
Trends in the Mortality of Hepatocellular Carcinoma in the United States.
-
Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.
-
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.
-
U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.
-
Underlying potential: cellular and molecular determinants of adult liver repair.
-
Understanding Factors Governing Distribution Volume of Ethyl Cellulose-Ethanol to Optimize Ablative Therapy in the Liver.
-
Universal Liver Imaging Lexicon: Imaging Atlas for Research and Clinical Practice.
-
Unknown primary tumors metastatic to liver.
-
Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.
-
Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication.
-
Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
-
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.
-
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
-
Updates and Critical Insights on Glissonian Approach in Liver Surgery.
-
Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth.
-
Use of bioluminescence imaging to detect enhanced hepatic and systemic tumor growth following partial hepatectomy in mice.
-
Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.
-
Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases.
-
User and system pitfalls in liver imaging with LI-RADS.
-
Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.
-
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.
-
Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
-
V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.
-
Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database.
-
Validation of lesion simulations in clinical CT data for anonymized chest and abdominal CT databases.
-
Value of PET/CT in the management of liver metastases, part 1.
-
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
-
Variability of quantitative measurements of metastatic liver lesions: a multi-radiation-dose-level and multi-reader comparison.
-
Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation.
-
Vascular invasion is a prognostic indicator in hepatoblastoma.
-
Vector-related tumorigenesis not found in ornithine transcarbamylase-deficient mice.
-
Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
-
Vitamins E and K induce aryl hydrocarbon hydroxylase activity in human cell cultures.
-
We've come a long way, baby!
-
White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
-
Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.
-
With proper imaging technique, is it still necessary to obtain images of the liver before administering contrast material in patients with known tumors who can have hypervascular liver metastases?
-
Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
-
Worse outcome of sorafenib therapy associated with ascites and Child-Pugh score in advanced hepatocellular carcinoma.
-
Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects.
-
[Comparison and analysis of clinicopathology of lung cancer between 1980s and 1990s in the Shenyang area (1,224 cases)].
-
[Intraportal injection of specific monoclonal antibody in nude mice with liver metastasis].
-
[Malignant melanoma: hepatic intra-arterial chemotherapy].
-
c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.
-
p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.
-
Keywords of People
-
Abbruzzese, James,
D. C. I. Distinguished Professor of Medical Oncology,
Medicine, Medical Oncology
-
Buckley, Anne Frances,
Assistant Professor of Pathology,
Pathology
-
Choi, Steven Sok,
Associate Professor of Medicine,
Medicine, Gastroenterology
-
Colsher, James George,
Adjunct Assistant Professor in the Department of Radiology,
Radiology
-
Hirschey, Matthew,
Associate Professor of Medicine,
Cell Biology
-
Hogan, Brigid L. M.,
Research Professor of Cell Biology,
Cell Biology
-
Jowell, Paul Simon,
Professor of Medicine,
Medicine, Gastroenterology
-
Sullivan, Daniel Carl,
Professor Emeritus of Radiology,
Radiology
-
Uronis, Hope Elizabeth,
Associate Professor of Medicine,
Medicine, Medical Oncology